Literature DB >> 8756669

Stable episomal maintenance of yeast artificial chromosomes in human cells.

K Simpson1, A McGuigan, C Huxley.   

Abstract

Plasmids carrying the Epstein-Barr virus origin of plasmid replication (oriP) have been shown to replicate autonomously in latently infected human cells (J. Yates, N. Warren, D. Reisman, and B. Sugden, Proc. Natl. Acad. Sci. USA 81:3806-3810, 1984). We demonstrate that addition of this domain is sufficient for stable episomal maintenance of yeast artificial chromosomes (YACs), up to at least 660 kb, in human cells expressing the viral protein EBNA-1. To better approximate the latent viral genome, YACs were circularized before addition of the oriP domain by homologous recombination in yeast cells. The resulting OriPYACs were maintained as extrachromosomal molecules over long periods in selection; a 90-kb OriPYAC was unrearranged in all cell lines analyzed, whereas the intact form of a 660-kb molecule was present in two of three cell lines. The molecules were also relatively stable in the absence of selection. This finding indicates that the oriP-EBNA-1 interaction is sufficient to stabilize episomal molecules of at least 660 kb and that such elements do not undergo rearrangements over time. Fluorescence in situ hybridization analysis demonstrated a close association of OriPYACs, some of which were visible as pairs, with host cell chromosomes, suggesting that the episomes replicate once per cell cycle and that stability is achieved by attachment to host chromosomes, as suggested for the viral genome. The wide availability of YAC libraries, the ease of manipulation of cloned sequences in yeast cells, and the episomal stability make OriPYACs ideal for studying gene function and control of gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756669      PMCID: PMC231512          DOI: 10.1128/MCB.16.9.5117

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Chromosomal region of the cystic fibrosis gene in yeast artificial chromosomes: a model for human genome mapping.

Authors:  E D Green; M V Olson
Journal:  Science       Date:  1990-10-05       Impact factor: 47.728

2.  Second-generation approach to the construction of yeast artificial-chromosome libraries.

Authors:  T Imai; M V Olson
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

3.  Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.

Authors:  J L Yates; N Guan
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Isolation of human sequences that replicate autonomously in human cells.

Authors:  P J Krysan; S B Haase; M P Calos
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

5.  Transfer of a yeast artificial chromosome carrying human DNA from Saccharomyces cerevisiae into mammalian cells.

Authors:  V Pachnis; L Pevny; R Rothstein; F Costantini
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Mapping the Drosophila genome with yeast artificial chromosomes.

Authors:  D Garza; J W Ajioka; D T Burke; D L Hartl
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

7.  Estimation of circular DNA size using gamma-irradiation and pulsed-field gel electrophoresis.

Authors:  S M Beverley
Journal:  Anal Biochem       Date:  1989-02-15       Impact factor: 3.365

8.  A human centromere antigen (CENP-B) interacts with a short specific sequence in alphoid DNA, a human centromeric satellite.

Authors:  H Masumoto; H Masukata; Y Muro; N Nozaki; T Okazaki
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

9.  Bam HI restriction fragment length polymorphisms for hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene of carriers and controls of HPRT deficiency in Japan.

Authors:  T Igarashi; H Ikegami; H Yamazaki; M Minami
Journal:  Acta Paediatr Jpn       Date:  1990-02

10.  Carrier detection of partial hypoxanthine-guanine phosphoribosyltransferase deficiency by analysis with BamHI restriction fragment length polymorphisms and oligonucleotide probes.

Authors:  T Igarashi; S Kamoshita
Journal:  Pediatr Res       Date:  1990-04       Impact factor: 3.756

View more
  28 in total

1.  Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.

Authors:  M A Lee; M E Diamond; J L Yates
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

Authors:  Hong Wu; Priya Kapoor; Lori Frappier
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Distinctive effects of the Epstein-Barr virus family of repeats on viral latent gene promoter activity and B-lymphocyte transformation.

Authors:  Ahmed K M Ali; Satoru Saito; Sachiko Shibata; Kenzo Takada; Teru Kanda
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

4.  Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.

Authors:  A L Kirchmaier; B Sugden
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  The minimal replicator of Epstein-Barr virus oriP.

Authors:  J L Yates; S M Camiolo; J M Bashaw
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA.

Authors:  J M Bashaw; J L Yates
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.

Authors:  A Aiyar; C Tyree; B Sugden
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

8.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

9.  Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2).

Authors:  Vipra Kapur Nayyar; Kathy Shire; Lori Frappier
Journal:  J Cell Sci       Date:  2009-11-03       Impact factor: 5.285

10.  Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells.

Authors:  Hanne A Askautrud; Elisabet Gjernes; Gro L Størvold; Mona M Lindeberg; Jim Thorsen; Hans Prydz; Eirik Frengen
Journal:  BMC Biotechnol       Date:  2009-10-16       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.